116 related articles for article (PubMed ID: 1700330)
1. Effects of intranigral substance P and neurokinin A on striatal dopamine release--II. Interactions with bicuculline and naloxone.
Reid MS; Herrera-Marschitz M; Ungerstedt U
Neuroscience; 1990; 36(3):659-67. PubMed ID: 1700330
[TBL] [Abstract][Full Text] [Related]
2. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
[TBL] [Abstract][Full Text] [Related]
3. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
Reid MS; Hökfelt T; Herrera-Marschitz M; Håkanson R; Feng DM; Folkers K; Goldstein M; Ungerstedt U
Brain Res; 1990 Nov; 532(1-2):175-81. PubMed ID: 1704289
[TBL] [Abstract][Full Text] [Related]
4. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments.
Reid MS; Herrera-Marschitz M; Terenius L; Ungerstedt U
Brain Res; 1990 Sep; 526(2):228-34. PubMed ID: 1701682
[TBL] [Abstract][Full Text] [Related]
5. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
[TBL] [Abstract][Full Text] [Related]
6. Striatal dopamine and glutamate release: effects of intranigral injections of substance P.
Reid MS; Herrera-Marschitz M; Kehr J; Ungerstedt U
Acta Physiol Scand; 1990 Dec; 140(4):527-37. PubMed ID: 1707211
[TBL] [Abstract][Full Text] [Related]
7. Effects of intranigral substance P and neurokinin A injections on extracellular dopamine levels measured with microdialysis in the striatum and frontoparietal cortex of rats.
Reid MS; Herrera-Marschitz M; Ungerstedt U
J Neurochem; 1991 Sep; 57(3):970-4. PubMed ID: 1713616
[TBL] [Abstract][Full Text] [Related]
8. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U
Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.
Reid M; Herrera-Marschitz M; Hökfelt T; Terenius L; Ungerstedt U
Eur J Pharmacol; 1988 Mar; 147(3):411-20. PubMed ID: 2454197
[TBL] [Abstract][Full Text] [Related]
10. Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat.
Tan DP; Tsou K
Brain Res; 1988 Mar; 443(1-2):310-4. PubMed ID: 2451993
[TBL] [Abstract][Full Text] [Related]
11. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons.
Baruch P; Artaud F; Godeheu G; Barbeito L; Glowinski J; Chéramy A
Neuroscience; 1988 Jun; 25(3):889-98. PubMed ID: 2457187
[TBL] [Abstract][Full Text] [Related]
12. Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat.
Humpel C; Saria A
Neurosci Lett; 1993 Jul; 157(2):223-6. PubMed ID: 7694197
[TBL] [Abstract][Full Text] [Related]
13. Intranigral GABAergic drug effects on striatal dopamine activity.
Sperber EF; Wurpel JN; Sharpless NS; Moshé SL
Pharmacol Biochem Behav; 1989 Apr; 32(4):1067-70. PubMed ID: 2477863
[TBL] [Abstract][Full Text] [Related]
14. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U
Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of tachykinins injected intranigrally on striatal dopamine metabolism.
Tan DP; Tsou K
J Neurochem; 1988 Nov; 51(5):1333-7. PubMed ID: 2459306
[TBL] [Abstract][Full Text] [Related]
16. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.
Herrera-Marschitz M; Christensson-Nylander I; Sharp T; Staines W; Reid M; Hökfelt T; Terenius L; Ungerstedt U
Exp Brain Res; 1986; 64(1):193-207. PubMed ID: 2429859
[TBL] [Abstract][Full Text] [Related]
17. [Effects of GABA and substance P on metabolism of striatal dopamine following experimental cerebral ischemia].
Li QY
Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):677-9, 702. PubMed ID: 7510213
[TBL] [Abstract][Full Text] [Related]
18. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
[TBL] [Abstract][Full Text] [Related]
19. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
[TBL] [Abstract][Full Text] [Related]
20. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
